New blood test could spot breast cancer earlier

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for Arm 1 (Target Population Arm) 1. 40 years of age and above. OR Between 18 and 39 years of age (inclusive) and a carrier of germline pathogenic variants associated with high risk of breast cancer: BRCA1, BRCA 2, PTEN, TP53, CDH1 or STK11 OR Between 18 and 39 years of age (inclusive) with a family history of breast or ovarian cancer involving at least one first or two second-degree relatives who were diagnosed with breast or ovarian cancer before the age of 50 years. 2. Assign female at birth. 3. Scheduled for routine annual breast cancer screening 4. Capable of giving consent for self, which includes compliance with the requirements and restriction listed in the Informed Consent and in the protocol. Inclusion Criteria for Arm 2 (Enriched Arm) 1. 40 years of age and above. OR Between 18 and 39 years of age (inclusive) and a carrier of germline pathogenic variants associated with high risk of breast cancer: BRCA1, BRCA 2, PTEN, TP53, CDH1 or STK11 OR Between 18 and 39 years of age (inclusive) with a family history of breast or ovarian cancer involving at least one first or two second-degree relatives who were diagnosed with breast or ovarian cancer before the age of 50 years. 2. Assigned female at birth 3. Scheduled for breast biopsy. 4. BI-RADS® screening score of 4B or above 5. Capable of giving consent for self, which includes compliance with the requirements and restriction listed in the Informed Consent and in the protocol. Exclusion Criteria (Both Arms) 1. Diagnosis with cancer within the past year. Individuals who underwent surgical removal of cancerous non-metastatic skin lesions can be recruited. 2. Has received any cancer treatments within the past year. 3. Has participated in another clinical study within the last 30 days. 4. Had bilateral surgery for breast cancer or for preventive reasons related to breast cancer. 5. Had a medical procedure in the chest cavity and/or airways within the past 2 weeks, which may interfere with the ability to provide a normal breath sample as required by the protocol.